NFE2L2 and Miyoshi myopathy: In our study, ChIP experiments and dual-luciferase-reporter assays revealed that Nrf2 directly transactivated FPN1 expression and inhibited miR-17-5p expression in MM, indicating that Nrf2 can modulate FPN1 levels directly or indirectly through miR-17-5p.